Representatives of African countries are meeting in Abuja this week to discuss the procurement and distribution of the H1N1 (swine flu) vaccine, the Daily Trust/allAfrica.com reports (Rabiu, 11/23).
The Associated Press/News-Observer examines revitalized vaccine research, including for such conditions as malaria, TB and HIV. “Vaccines are no longer a sleepy, low-profit niche in a booming drug industry. Today, they’re starting to give ailing pharmaceutical makers a shot in the arm,” according to the article.
Also In Global Health News: Vaccination Campaign In Liberia; Cell Phones For Family Planning Services; Global Fund In Myanmar
Liberia Aims To Reach 3M With Yellow Fever Vaccine Liberia’s Daily Observer reports on a yellow fever vaccination campaign to begin this week that will aim to inoculate 3 million Liberians.Â Supported by the country’s Ministry of Health and Social Welfare, UNICEF, USAID, and WHO, the initiative is in response to…
Experts at an American Society of Tropical Medicine and Hygiene meeting this week said that resistance to the best available drug to treat malaria “is more widespread in Southeast Asia than previously reported,” Science News/Wired Science reports.
The deaths of 41 people from six countries who had received the H1N1 (swine flu) vaccine were not directly linked to the vaccine, the WHO said Thursday, the Associated Press/MSNBC reports (11/19).
U.S. health officials defended their handling of the country’s H1N1 (swine flu) vaccine campaign Tuesday “against criticism that their plan to protect Americans was confusing and over-optimistic,” Reuters reports (Fox, 11/17).
The WHO on Tuesday announced it would lead a week-long, multi-country vaccination campaign in Africa next week to protect those “deemed at highest risk from yellow fever,” Reuters reports. The vaccination drive will target nearly 12 million Africans living in Benin, Liberia and Sierra Leone â€“ all countries at high risk of yellow fever outbreaks (Nebehay/MacInnis, 11/17).
The “co-ordinated buying policy” of the GAVI Alliance has driven down “[t]he price of a vaccine that helps babies fight off killer diseases,” according to data released by the group, Reuters reports. In 2010, the price of pentavalent vaccine, which protects against Hib (Haemophilus influenzae type b), diphtheria, whooping cough, tetanus and hepatitis B, will fall “below $3.0 â€“ a drop of almost $0.50 cents per dose on the 2009 price,” according to the news services.
Global Corruption Fight Slowing, Report Says A new report from Transparency International says the fight against corruption worldwide is slowing as urgency to address the global economic downturn recedes, Bloomberg reports. “This yearâ€™s index, which measures the perception of corruption in a country, showed that 129 of the 180 nations…
Chinese and WHO officials last week agreed to open a flu research center in Beijing, Bloomberg reports. “The new collaborating center for reference and research on influenza will join a network of WHO-affiliated labs in Atlanta, London, Tokyo and Melbourne that monitor flu strains and make recommendations on vaccines to fight the virus,” the news service writes.